The effects of a new imidazole derivative in advanced prostatic cancer. A preliminary report.
Mahler
C
C
Dept. Endocrinology, A.Z. Middelheim, Antwerp, Belgium.
Denis
L
L
De Coster
R
R
D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D007093:Imidazoles; D017430:Prostate-Specific Antigen; C061121:liarozole; D007654:Ketoconazole